
The Danish biotech company Nuevolution has managed to raise DKK 80.5 million in a financing round, announces one of the company’s investors Sunstone Capital in a press release.
The round was led by Industrifonden, which put up the bulk of the capital, but Nuevolutions existing investors Sunstone Capital, SEB Venture Capital and SEB Utvecklingsstiftelse took part as well.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app